-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Some prospective cohort studies have reported a significant correlation between serum total non-esterified fatty acid (NEFA) concentration and coronary heart disease (CHD) mortality and non-fatal myocardial infarction (MI) incidence.
Myocardial infarction
Recently, the medsci.
medsci.
During a median follow-up of 11.
Exploratory analysis showed that lauric acid (12:0) was negatively correlated with CHD mortality (hazard ratio [HR] was 0.
Among the CHS participants, two NEFAs (dihomo-γ-linolenic acid and elaidic acid) were positively correlated with CHD mortality and non-fatal MI, suggesting that they are the potential risks of CHD death and non-fatal MI Susceptibility biomarkers .
Two NEFAs (dihomo-γ-linolenic acid and elaidic acid) are positively correlated with CHD mortality and non-fatal MI, respectively, suggesting that they are potential susceptibility biomarkers for CHD death and non-fatal MI risk
Original source:
Original source:Neil K.
Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort in this message